As Chair of the Board Nominating Committee, I am asking for your help to identify colleagues within ISPE who would be well-suited to serve on the ISPE International Board of Directors. The International Board of Directors is responsible for the governance and strategic direction of our Society. Members of the Board are people who know our Society, understand our industry and have strong strategic leadership capabilities. Potential candidates should have most, if not all, of the following characteristics:
In an effort to represent a global view of our industry and to ensure organizational success, it is important we have an appropriately diverse International Board of Directors. Diversity is represented in many ways; examples may include business expertise, gender, geographic location and young professionals. If you know of someone who fits the above description and can expand our Board diversity, I encourage you to reach out to them, confirm their willingness to be considered, and send a completed Nomination Form along with the nominee's curriculum vitae or resume to nominations@ispe.org by 14 April 2017. Self-nominations are also welcome. Thank you for your help with this critical task for ISPE.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...